Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types
C. P. McCormack, A. W. C. Yan, J. C. Brown, K. Sukhova, T. P. Peacock, W. S. Barclay, I. Dorigatti
Abstract
We use viral kinetic models fitted to viral load data from in vitro studies to explain why the SARS-CoV-2 Omicron variant replicates faster than the Delta variant in nasal cells, but slower than Delta in lung cells, which could explain Omicrons higher transmission potential and lower severity. We find that in both nasal and lung cells, viral infectivity is higher for Omicron but the virus production rate is higher for Delta. However, the differences are unequal between cell types, and ultimately leads to the basic reproduction number and growth rate being higher for Omicron in nasal cells, and higher for Delta in lung cells. In nasal cells, Omicron alone can enter via a TMPRSS2-independent pathway, but it is primarily increased efficiency of TMPRSS2-dependent entry which accounts for Omicrons increased activity. This work paves the way for using within-host mathematical models to understand the transmission potential and severity of future variants.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
N. S. Tanneti, A. K. Patel, … S. R. Weiss·bioRxiv·Aug 24, 2023
- SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium
M. M. Lamers, A. Z. Mykytyn, … B. L. Haagmans·bioRxiv·Jan 19, 2022
- Modeling predicts mechanisms altered by mutations of the SARS-CoV-2 delta and omicron variants
J. Pearson, T. Wessler, … M. G. Forest·bioRxiv·Feb 23, 2022
- Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
- The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection
M. Martins, G. M. do Nascimento, … D. G. Diel·bioRxiv·Jun 15, 2022
- In vitro comparison of SARS-CoV-2 variants
K. S. Phadke, N. B. A. Higdon, B. H. Bellaire·bioRxiv·Mar 11, 2023